MedPage Today on MSN

What Are the Goalposts for Present and Future ATTR-CM Therapies?

With several disease-modifying therapies available for transthyretin amyloid cardiomyopathy (ATTR-CM) -- and more waiting in ...
Healio

VIDEO: Clinical assessment 'most important aspect' in monitoring ATTR-CM progression

Well, after the treatment for transthyretin cardiac amyloidosis has started, our main focus is to look at the progression of ...
TCTMD

Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM

The exploratory, post hoc look at the trial shows curves starting to separate by month 1, supporting earlier treatment.
pharmaphorum

Alnylam's Onpattro clears FDA vote for ATTR-cardiomyopathy

Despite a sceptical appraisal by FDA reviewers, Alnylam's Onpattro has been recommended for approval as a treatment for transthyretin amyloidosis cardiomyopathy (ATTR-CM) by the regulator's advisors.